[1]
Cho A, Howell VM, Colvin EK. The extracellular matrix in epithelial ovarian cancer - A piece of a puzzle. Front Oncol 2015; 5: 245.
[2]
Ha TY. MicroRNAs in human diseases: from cancer to cardiovascular disease. Immune Netw 2011; 11(3): 135-54.
[3]
Vychytilova-Faltejskova P, Slaby O. Circulating blood-borne micrornas as biomarkers in solid tumors. Exp Suppl 2015; 106: 75-122.
[4]
Kim TH, Song JY, Park H, et al. miR-145, targeting high-mobility group A2, is a powerful predictor of patient outcome in ovarian carcinoma. Cancer Lett 2015; 28; 356[2 Pt B]: 937-45.
[5]
Liang H, Jiang Z, Xie G, Lu Y. Serum microRNA-145 as a novel biomarker in human ovarian cancer. Tumor Biol J Int Soc Oncodevelop Biol Med 2015; 36(7): 5305-13.
[6]
Dong R, Liu X, Zhang Q, et al. miR-145 inhibits tumor growth and metastasis by targeting metadherin in high-grade serous ovarian carcinoma. Oncotarget 2014; 5(21): 10816-29.
[7]
Zhu X, Li Y, Xie C, et al. miR-145 sensitizes ovarian cancer cells to paclitaxel by targeting Sp1 and Cdk6. Int J Cancer J Int Cancer 2014; 135(6): 1286-96.
[8]
Ding W, Tan H, Zhao C, et al. MiR-145 suppresses cell proliferation and motility by inhibiting ROCK1 in hepatocellular carcinoma. Tumour Biol 2016; 37(5): 6255-60.
[9]
Akao Y, Nakagawa Y, Naoe T. MicroRNA-143 and -145 in colon cancer. DNA Cell Biol 2007; 26(5): 311-20.
[10]
Akao Y, Nakagawa Y, Naoe T. MicroRNAs 143 and 145 are possible common onco-microRNAs in human cancers. Oncol Rep 2006; 16(4): 845-50.
[11]
Xu X, Wu X, Jiang Q, et al. Downregulation of microRNA-1 and microRNA-145 contributes synergistically to the development of colon cancer. Int J Mol Med 2015; 36(6): 1630-8.
[12]
Odenthal M, Hee J, Gockel I, et al. Serum microRNA profiles as prognostic/predictive markers in the multimodality therapy of locally advanced adenocarcinomas of the gastroesophageal junction. Int J Cancer 2015; 137(1): 230-7.
[13]
Zuberi M, Mir R, Das J, et al. Expression of serum miR-200a, miR-200b, and miR-200c as candidate biomarkers in epithelial ovarian cancer and their association with clinicopathological features. Clin Transl Oncol 2015; 17(10): 779-87.
[14]
Zuberi M, Khan I, Gandhi G, Ray PC, Saxena A. The conglomeration of diagnostic, prognostic and therapeutic potential of serum miR-199a and its association with clinicopathological features in epithelial ovarian cancer. Tumour Biol 2016; 37(8): 11259-66.
[16]
Sim JA, Abdul RK, Yi KJ, Chung M, et al. High microRNA-370 expression correlates with tumor progression and poor prognosis in breast cancer. J Breast Cancer 2015; 18(4): 323-8.
[17]
Bertoli G, Cava C, Castiglioni I. MicroRNAs: new biomarkers for diagnosis, prognosis, therapy prediction and therapeutic tools for breast cancer. Theranostics 2015; 5(10): 1122-43.
[18]
Eissa S, Matboli M, Sharawy A, El-Sharkawi F. Prognostic and biological significance of microRNA-221 in breast cancer. Gene 2015; 574(1): 163-7.
[19]
Vescovo VD, Denti MA. microRNA and lung cancer. Adv Exp Med Biol 2015; 889: 153-77.
[20]
Li W, Wang Y, Zhang Q, et al. MicroRNA-486 as a biomarker for early diagnosis and recurrence of non-small cell lung cancer. PLoS One 2015; 10(8)e0134220 [doi: 10.1371/journal.pone.0134220].
[21]
Khan MA, Zubair H, Srivastava SK, Singh S, Singh AP. Insights into the role of microRNAs in pancreatic cancer pathogenesis: potential for diagnosis, prognosis, and therapy. Adv Exp Med Biol 2015; 889: 71-87.
[22]
Paik WH, Song BJ, Kim HW, Kim HR, Hwang JH. MicroRNA-200c as a prognostic biomarker for pancreatic cancer. Korean J Gastroenterol 2015; 66(4): 215-20.
[23]
Zhao Y, Liu X, Zhong L, et al. The combined use of miRNAs and mRNAs as biomarkers for the diagnosis of papillary thyroid carcinoma. Int J Mol Med 2015; 36(4): 1097-103.
[24]
Sondermann A, Andreghetto FM, Moulatlet ACB, et al. MiR-9 and miR-21 as prognostic biomarkers for recurrence in papillary thyroid cancer. Clin Exp Metastasis 2015; 32(6): 521-30.
[25]
Ress AL, Perakis S, Pichler M. microRNAs and colorectal cancer. Adv Exp Med Biol 2015; 889: 89-103.
[26]
Thomas J, Ohtsuka M, Pichler M, Ling H. MicroRNAs: clinical relevance in colorectal cancer. Int J Mol Sci 2015; 16(12): 28063-76.
[27]
Sun X, Zhang S, Ma X. Prognostic value of microRNA-125 in various human malignant neoplasms: a meta-analysis. Clin Lab 2015; 61(11): 1667-74.
[28]
Miles GD, Seiler M, Rodriguez L, Rajagopal G, Bhanot G. Identifying microRNA/mRNA dysregulations in ovarian cancer. BMC Res Notes 2012; 5: 164. [doi: 10.1186/1756-0500-5-164].
[29]
Chen Z, Zeng H, Guo Y, et al. miRNA-145 inhibits non-small cell lung cancer cell proliferation by targeting c-Myc. J Exp Clin Cancer Res 2010; 29: 151.
[30]
Zhang Y, Yang X, Wu H, Zhou W, Liu Z. MicroRNA-145 inhibits migration and invasion via inhibition of fascin 1 protein expression in non-small-cell lung cancer cells. Mol Med Rep 2015; 12(4): 6193-8.
[31]
Kliese N, Gobrecht P, Pachow D, et al. miRNA-145 is downregulated in atypical and anaplastic meningiomas and negatively regulates motility and proliferation of meningioma cells. Oncogene 2013; 32(39): 4712-20.
[32]
Zheng L, Pu J, Qi T, et al. miRNA-145 targets v-ets erythroblastosis virus E26 oncogene homolog 1 to suppress the invasion, metastasis, and angiogenesis of gastric cancer cells. Mol Cancer Res 2013; 11(2): 182-93.
[33]
Pal A, Melling G, Hinsley EE, et al. Cigarette smoke condensate promotes pro-tumorigenic stromal-epithelial interactions by suppressing miR-145. J Oral Pathol Med 2013; 42(4): 309-14.
[34]
Noguchi S, Mori T, Hoshino Y, et al. Comparative study of anti-oncogenic microRNA-145 in canine and human malignant melanoma. J Vet Med Sci 2012; 74(1): 1-8.
[35]
Yang C, Wei W. The miRNA expression profile of the uveal melanoma. Sci China Life Sci 2011; 54(4): 351-8.
[36]
Blick C, Ramachandran A, McCormick R, et al. Identification of a hypoxia-regulated miRNA signature in bladder cancer and a role for miR-145 in hypoxia-dependent apoptosis. Br J Cancer 2015; 113(4): 634-44.
[37]
Qin J, Wang F, Jiang H, Xu J, Jiang Y, Wang Z. MicroRNA-145 suppresses cell migration and invasion by targeting paxillin in human colorectal cancer cells. Int J Clin Exp Pathol 2015; 8(2): 1328-40.
[38]
Yu Y, Nangia-Makker P, Farhana L, Rajendra GS, Levi E, Majumdar AP. miR-21 and miR-145 cooperation in regulation of colon cancer stem cells. Mol Cancer 2015; 14: 98.
[39]
Li MY, Hu XX. Meta-analysis of microRNA expression profiling studies in human cervical cancer. Med Oncol 2015; 32(6): 510.
[40]
Ramzy I, Hasaballah M, Marzaban R, Shaker O, Soliman ZA. Evaluation of microRNAs-29a, 92a and 145 in colorectal carcinoma as candidate diagnostic markers: an Egyptian pilot study. Clin Res Hepatol Gastroenterol 2015; 39(4): 508-15.
[41]
Wang C, Tao W, Ni S, et al. Tumor-suppressive microRNA-145 induces growth arrest by targeting SENP1 in human prostate cancer cells. Cancer Sci 2015; 106(4): 375-82.
[42]
Zheng H, Liu Z, Liu T, et al. Fas signaling promotes chemoresistance in gastrointestinal cancer by up-regulating P-glycoprotein. Oncotarget 2014; 5(21): 10763-77.
[43]
Yuan W, Sui C, Liu Q, Tang W, An H, Ma J. Up-regulation of microRNA-145 associates with lymph node metastasis in colorectal cancer. PLoS One 2014; 9(7)e102017
[44]
Tsikitis VL, White I, Mori M, et al. Differential expression of microRNA-320a, -145, and -192 along the continuum of normal mucosa to high-grade dysplastic adenomas of the colorectum. Am J Surg 2014; 207(5): 717-22.
[45]
Shi L, Wang Z, Sun G, Wan Y, Guo J, Fu X. miR-145 inhibits migration and invasion of glioma stem cells by targeting ABCG2. Neuromolecular Med 2014; 16(2): 517-28.
[46]
Chen X, Dong C, Law PTY, et al. MicroRNA-145 targets TRIM2 and exerts tumor-suppressing functions in epithelial ovarian cancer. Gynecol Oncol 2015; 139(3): 513-9.
[47]
Wang L, Wang B, Fang M, Guo F, Cui M. Identification of microRNAs and target genes involved in serous ovarian carcinoma and their influence on survival. Eur J Gynaecol Oncol 2014; 35(6): 655-61.
[48]
Wu H, Xiao Z, Wang K, Liu W, Hao Q. MiR-145 is downregulated in human ovarian cancer and modulates cell growth and invasion by targeting p70S6K1 and MUC1. Biochem Biophys Res Commun 2013; 441(4): 693-700.
[49]
Zhang W, Wang Q, Yu M, Wu N, Wang H. MicroRNA-145 function as a cell growth repressor by directly targeting c-Myc in human ovarian cancer. Technol Cancer Res Treat 2014; 13(2): 161-8.
[50]
Chung YW, Bae HS, Song JY, et al. Detection of microRNA as novel biomarkers of epithelial ovarian cancer from the serum of ovarian cancer patients. Int J Gynecol Cancer 2013; 23(4): 673-9.
9